POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER

This adverse event was reported 5095 times

These drugs are most commonly taken by patients reporting POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER:

# Drug Count
0 TACROLIMUS 3126
1 TACROLIMUS EXTENDED-RELEASE CAPSULES 2975
2 TACROLIMUS OINTMENT 0.1% 2975
3 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 2343
4 MYCOPHENOLATE MOFETIL 2342
5 PREDNISONE 1711
6 PREDNISOLONE 972
7 PREDNISOLONE ORAL 972
8 PREDNISOLONE ORAL SOLUTION 972
9 RITUXIMAB 956
See all common drugs associated with POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER

POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GANCICLOVIR SODIUM 268 0.0250
1 ANTI-THYMOCYTE GLOBULIN (RABBIT) 201 0.0247
2 TACROLIMUS OINTMENT 0.1% 2975 0.0234
3 TACROLIMUS EXTENDED-RELEASE CAPSULES 2975 0.0233
4 BASILIXIMAB 263 0.0220
5 BELATACEPT 95 0.0200
6 LETERMOVIR 65 0.0200
7 TACROLIMUS 3126 0.0196
8 MYCOPHENILIC ACID 399 0.0187
9 TREOSULFAN 49 0.0178
See all drugs enriched for association with POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER